Veeva：2024年制药活动的新规则：混合时代的成功手册（英文版）

Over the last two years, the way pharma companies run events for healthcare professionals (HCPs) underwent two significant transitions. First, they went from mostly face-to-face to exclusively virtual out of necessity during the pandemic; second, they went from entirely virtual to the new hybrid era, out of choice. And while digital events have increased 600% relative to pre-pandemic,1 in-person events are back and highly valued, especially for providing education and support to HCPs. When as